A

Alkermes plc
D

ALKS

26.120
USD
-0.41
(-1.55%)
مغلق
حجم التداول
74,651
الربح لكل سهم
1
العائد الربحي
-
P/E
12
حجم السوق
4,307,221,564
أصول ذات صلة
ABBV
ABBV
-0.465
(-0.24%)
190.325 USD
AZN
AZN
-1.055
(-1.43%)
72.640 USD
BMY
BMY
-0.525
(-1.07%)
48.455 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
JNJ
JNJ
-1.240
(-0.73%)
168.350 USD
LLY
LLY
8.95
(1.11%)
812.95 USD
MRK
MRK
0.570
(0.68%)
84.730 USD
NVS
NVS
0.260
(0.22%)
117.680 USD
PFE
PFE
-0.555
(-2.19%)
24.810 USD
SNY
SNY
0.230
(0.46%)
50.370 USD
TEVA
TEVA
0.195
(1.19%)
16.545 USD
المزيد
الأخبار المقالات

العنوان: Alkermes plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.